Human BDCA2⁺CD123⁺CD56⁺ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset

Abstract

Dendritic cells (DCs) comprise two functionally distinct subsets: plasmacytoid DCs (pDCs) and myeloid DCs (mDCs). pDCs are specialized in rapid and massive secretion of type I interferon (IFN-I) in response to nucleic acids through Toll like receptor (TLR)-7 or TLR-9. In this report, we characterized a CD56⁺ DC population that express typical pDC markers including CD123 and BDCA2 but produce much less IFN-I comparing with pDCs. In addition, CD56⁺ DCs cluster together with mDCs but not pDCs by genome-wide transcriptional profiling. Accordingly, CD56⁺ DCs functionally resemble mDCs by producing IL-12 upon TLR4 stimulation and priming naïve T cells without prior activation. These data suggest that the CD56⁺ DCs represent a novel mDC subset mixed with some pDC features. A CD4⁺CD56⁺ hematological malignancy was classified as blastic plasmacytoid dendritic cell neoplasm (BPDCN) due to its expression of characteristic molecules of pDCs. However, we demonstrated that BPDCN is closer to CD56⁺ DCs than pDCs by global gene-expression profiling. Thus, we propose that the CD4⁺CD56⁺ neoplasm may be a tumor counterpart of CD56⁺ mDCs but not pDCs.

Keywords

dendritic cells / CD56⁺ DC / pDC / mDC / BPDCN

References

[1] Adachi M, Maeda K, Takekawa M (1994) High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol47(4): 278-282

[2] Alter O, Brown PO, Botstein D (2000) Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA97(18): 10101-10106

[3] An HJ, Yoon DH, Kim S (2013) Blastic plasmacytoid dendritic cell neoplasm: a single-center experience. Ann Hematol92(3): 351-356

[4] Brody JP, Allen S, Schulman P (1995) Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents. Cancer75(10): 2474-2483

[5] Cao W, Rosen DB, Ito T (2006) Plasmacytoid dendritic cellspecific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med203(6): 1399-1405

[6] Cella M, Jarrossay D, Facchetti F (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med5(8): 919-923

[7] Cerboni S, Gentili M, Manel N (2013) Diversity of pathogen sensors in dendritic cells. Adv Immunol120: 211-237

[8] Chaperot L, Bendriss N, Manches O (2001) Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood97(10): 3210-3217

[9] Cisse B, Caton ML, Lehner M (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell135(1): 37-48

[10] Comeau MR (2002) Van der Vuurst de Vries AR, Maliszewski CR, Galibert L. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol169(1): 75-83

[11] Defays A, David A, de Gassart A (2011) BAD-LAMP is a novel biomarker of nonactivated human plasmacytoid dendritic cells. Blood118(3): 609-617

[12] Du P, Kibbe WA, Lin SM (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics24(13): 1547-1548

[13] Dzionek A, Fuchs A, Schmidt P (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol165(11): 6037-6046

[14] Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA95(25): 14863-14868

[15] Esashi E, Bao M, Wang YH, Cao W, Liu YJ (2012) PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells. Eur J Immunol42(3): 573-579

[16] Facchetti F, Jones D, Petrella T (2008) Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow S, Campo E, Harris N (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer (IARC), Lyon, pp 145-147

[17] Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B (2010) Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity33(6): 905-916

[18] Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ (1997) The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med185(6): 1101-1111

[19] Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D (2003) TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4⁺ CD56⁺ blastic tumors of skin. Blood101(12): 5007-5009

[20] Kadowaki N, Ho S, Antonenko S (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med194(6): 863-869

[21] Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol23: 275-306

[22] Marafioti T, Paterson JC, Ballabio E (2008) Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood111(7): 3778-3792

[23] Maric M, Arunachalam B, Phan UT (2001) Defective antigen processing in GILT-free mice. Science294(5545): 1361-1365

[24] Matsui T, Connolly JE, Michnevitz M (2009) CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J Immunol182(11): 6815-6823

[25] Petrella T, Facchetti F (2010) Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009? Autoimmunity43(3): 210-214

[26] Petrella T, Dalac S, Maynadie M (1999) CD4⁺ CD56⁺ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d’Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol23(2): 137-146

[27] Petrella T, Comeau MR, Maynadie M (2002) ‘Agranular CD4⁺ CD56⁺ hematodermic neoplasm’ (blastic NK-cell lymphoma) originates from a population of CD56⁺ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol26(7): 852-862

[28] Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS (2007) CD4⁺/ CD56⁺ hematodermic neoplasm (“blastic natural killer cell lymphoma”): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol128(3): 445-453

[29] Rissoan MC, Duhen T, Bridon JM (2002) Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood100(9): 3295-3303

[30] Robbins SH, Walzer T, Dembele D (2008) Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol9(1): R17

[31] Sapienza MR, Fuligni F, Agostinelli C (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia28: 1606-1616

[32] Schotte R, Nagasawa M, Weijer K, Spits H, Blom B (2004) The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J Exp Med200(11): 1503-1509

[33] Siegal FP, Kadowaki N, Shodell M (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science284(5421): 1835-1837

[34] Singh R, Cresswell P (2010) Defective cross-presentation of viral antigens in GILT-free mice. Science328(5984): 1394-1398

[35] Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol3: 1-25

[36] Steinman RM (2007) Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med13(10): 1155-1159

[37] Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics25(9): 1105-1111

[38] Uchiyama N, Ito K, Kawai K, Sakamoto F, Takaki M, Ito M (1998) CD2^-, CD4⁺, CD56⁺ agranular natural killer cell lymphoma of the skin. Am J Dermatopathol20(5): 513-517

[39] Vermi W, Facchetti F, Rosati S (2004) Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol28(5): 585-595

[40] Ziegler-Heitbrock L, Ancuta P, Crowe S (2010) Nomenclature of monocytes and dendritic cells in blood. Blood116(16): e74-e80

RIGHTS & PERMISSIONS

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.